Wikidata entity: Q96695265
| P373 | Commons category | String | Convidecia | ??? |
| P1343 | described by source | ... | Q87931195 (A Single-center,Open-label，Dose-escalating Phase I Clinical Trial to Evaluate Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Healthy Adults Aged 18-60 Years Old (inglês)) | A Single-center,Open-label，Dose-escalating Phase I Clinical Trial to Evaluate Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Healthy Adults Aged 18-60 Years Old (inglês) |
| P1343 | described by source | ... | Q90693178 (A Phase II Clinical Trial to Evaluate the Recombinant Novel Coronavirus Vaccine (Adenovirus Vector)) | A Phase II Clinical Trial to Evaluate the Recombinant Novel Coronavirus Vaccine (Adenovirus Vector) |
| P1343 | described by source | ... | Q95056331 (Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in Canada) | Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in Canada |
| P1343 | described by source | ... | Q98767321 (A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector)) | A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector) |
| P1343 | described by source | ... | Q98767346 (A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)) | A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector) |
| P1343 | described by source | ... | Q99956128 (Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19) | Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 |
| P1343 | described by source | ... | Q100157869 (Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above) | Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above |
| P1343 | described by source | ... | Q95818623 (???) | ??? |
| P1343 | described by source | ... | Q97678477 (???) | ??? |
| P178 | developer | ... | Q10872936 (PLA Academy of Military Medical Sciences) | PLA Academy of Military Medical Sciences |
| P178 | developer | ... | Q91016085 (CanSino Biologics) | CanSino Biologics |
| P31 | instance of | ... | Q134808 (vaccine) | vaccine |
| P176 | manufacturer | ... | Q99518786 (Petrovax) | Petrovax |
| P1448 | official name | Monolingualtext | Convidecia | ??? |
| P1448 | official name | Monolingualtext | PakVak | ??? |
| P5008 | on focus list of Wikimedia project | ... | Q87748614 (WikiProject COVID-19) | WikiProject COVID-19 |
| P636 | route of administration | ... | Q432083 (intramuscular injection) | intramuscular injection |
| P1909 | side effect | ... | Q9690 (fatigue) | fatigue |
| P1909 | side effect | ... | Q38933 (fever) | fever |
| P1909 | side effect | ... | Q81938 (pain) | pain |
| P793 | significant event | ... | Q5452194 (phase I clinical trial) | phase I clinical trial |
| P279 | subclass of | ... | Q28051899 (vaccine candidate) | vaccine candidate |
| P279 | subclass of | ... | Q87719492 (COVID-19 vaccine) | COVID-19 vaccine |
| P279 | subclass of | ... | Q96841548 (adenovirus-based vaccine) | adenovirus-based vaccine |
| P1924 | vaccine for | ... | Q84263196 (COVID-19) | COVID-19 |
| P267 | ATC code | J07BX03 |
| P715 | DrugBank ID | DB15655 |
| P2671 | Google Knowledge Graph ID | /g/11n04t1m_2 |
| P652 | UNII | 5AHC3V2UQS |
| P1928 | Vaccine Ontology ID | VO_0005144 |
| P1925 | VIOLIN ID | 5768 |
Why not click here or view trends?
log id: 5652501